1月6日,Arrowhead美股盘前涨超13%!公司的基因沉默药物在肥胖症早期临床试验中实现减脂效果。
1月6日,Arrowhead美股盘前涨超13%!公司的基因沉默药物在肥胖症早期临床试验中实现减脂效果。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.